Societies, Congresses, and Industry Events
Botulinum toxin research and clinical use span several professional fields, from neurotoxin science and neurology to rehabilitation medicine, dermatology, plastic surgery, and aesthetic medicine. The meetings connected to these fields differ in scientific scope, clinical focus, and commercial participation.
INA and TOXINS are the closest to dedicated neurotoxin science. AAN and AAPM&R place botulinum toxin within therapeutic specialist practice, while IMCAS, AMWC, Vegas Cosmetic Surgery, The Aesthetic Show, and AMWC Korea connect clinical education with the wider medical-aesthetics industry. Their schedules provide a chronological view of where research exchange, professional education, and product visibility occur.
2026 Major Event Calendar
Section titled “2026 Major Event Calendar”The main 2026 meetings connected to the organizations and congress brands covered here span neurotoxin science, therapeutic specialties, and medical aesthetics. Dates refer to the principal congress or annual meeting rather than optional pre-congress courses, registration deadlines, or on-demand access periods.
| Date | Event | Location and format | Status |
|---|---|---|---|
| January 14–17 | TOXINS 2026 🔗 | Madrid, Spain | Concluded |
| January 29–31 | IMCAS World Congress 2026 🔗 | Paris, France, and online | Concluded |
| March 26–28 | AMWC 2026 🔗 | Monte Carlo, Monaco | Concluded |
| April 18–22 | AAN Annual Meeting 🔗 | Chicago, United States, and online | Concluded |
| May 28–30 | Vegas Cosmetic Surgery & Aesthetic Dermatology 🔗 | Las Vegas, United States | Concluded |
| June 19–20 | AMWC Korea 🔗 | Seoul, South Korea | Concluded |
| June 25–28 | The Aesthetic Show 🔗 | Las Vegas, United States | Concluded |
| September 12–13 | AMWC Japan 2026 🔗 | The Prince Park Tower Tokyo, Japan | Registration open; program available |
| November 11–14 | AAPM&R Annual Assembly | Orlando, United States, and virtual | Registration open; interactive agenda available |
Event dates and formats can change; the linked organizer pages remain the controlling source for registration and travel decisions.
Next Announced Editions
Section titled “Next Announced Editions”Several organizers have already published dates for their next annual meeting. Other series remain listed by their most recently confirmed edition until a new date is announced.
| Date | Event | Location and format | Planning status |
|---|---|---|---|
| January 28–30, 2027 | IMCAS World Congress 2027 🔗 | Paris, France, and online | Registration and abstract submission open; preliminary program available |
| April 1–3, 2027 | AMWC Cannes 2027 | Cannes, France | Registration and abstract submission open |
| May 1–5, 2027 | AAN Annual Meeting 2027 | Washington, DC, United States, and online | Dates and format confirmed; registration pending |
| June 4–5, 2027 | AMWC Korea 2027 | InterContinental Grand Seoul Parnas, Seoul, South Korea | Venue confirmed; registration and abstract submission opening soon |
| July 8–11, 2027 | The Aesthetic Show 2027 🔗 | Wynn Las Vegas, United States | Registration and abstract submission open |
| November 10–13, 2027 | AAPM&R Annual Assembly 2027 🔗 | Phoenix Convention Center, Phoenix, United States | Dates and venue confirmed; registration pending |
| November 2027; exact dates pending | AMWC Japan 2027 | Japan; city and venue pending | Month confirmed at planning level |
The International Neurotoxin Association has identified TOXINS 2028 as the next edition of its dedicated conference series, but it has not yet published dates or a location. For Vegas Cosmetic Surgery 2027, the IM-Aesthetics North America calendar 🔗 lists Fontainebleau Las Vegas, but exact dates remain unannounced.
Upcoming Planning Deadlines
Section titled “Upcoming Planning Deadlines”| Deadline | Event | Action |
|---|---|---|
| October 13, 2026 | AAPM&R Annual Assembly 2026 | Mail and fax registration cutoff; fax submissions close at 4:00 pm Central Time. AAPM&R registration details 🔗 |
| October 15, 2026 | The Aesthetic Show 2027 | Educational presentation abstract deadline 🔗 |
| October 29, 2026 | AMWC Cannes 2027 | Super-early-bird registration period ends 🔗 |
| October 31, 2026 | AMWC Cannes 2027 | Oral-presentation abstract deadline 🔗 |
| December 31, 2026 | AMWC Cannes 2027 | Poster submission deadline 🔗 |
Core Neurotoxin Organizations
Section titled “Core Neurotoxin Organizations”International Neurotoxin Association
Section titled “International Neurotoxin Association”The International Neurotoxin Association (INA) is the most directly relevant scientific society for this field. It describes itself as a not-for-profit international scientific society dedicated to research, education, and understanding of botulinum and other neurotoxins.
INA keeps botulinum toxin inside a broader neurotoxin-science frame rather than treating it only as a cosmetic injectable or a product category. Its membership and programming connect basic science, clinical use, and cross-specialty interpretation.
Following the concluded Madrid meeting, INA identifies TOXINS 2028 as the next conference edition. Dates, location, registration, abstract submission, and program information remain unannounced.
Website: International Neurotoxin Association 🔗
TOXINS Conference
Section titled “TOXINS Conference”TOXINS is INA’s international conference series focused on basic science and clinical aspects of botulinum and other neurotoxins. The 2026 conference page described the meeting as a venue for developments in neurotoxin science and clinical applications, with relevance to neurology, physical medicine and rehabilitation, dermatology, aesthetic medicine, ophthalmology, otolaryngology, urology, gastroenterology, and pain management.
TOXINS is the most focused event anchor for botulinum toxin as a scientific and clinical category. It is more specific than broad dermatology or aesthetics congresses and sits near the center of the field’s event landscape.
Website: TOXINS 2026 🔗
Therapeutic Clinical Fields
Section titled “Therapeutic Clinical Fields”American Academy of Neurology
Section titled “American Academy of Neurology”The American Academy of Neurology (AAN) is not a botulinum toxin-specific society, but neurology is one of the major therapeutic contexts in which botulinum toxin products are discussed. Movement disorders, dystonia, spasticity-adjacent care, chronic migraine, and other neurologic treatment contexts make AAN meetings and educational materials relevant to the medical side of the toxin field.
The AAN Annual Meeting 2027 is scheduled for May 1–5 in Washington, DC, and online. The Annual Meeting is a broad neurology meeting rather than a product meeting, connecting regulated products and neurologic indications with clinical evidence and specialist practice.
Website: American Academy of Neurology Annual Meeting 🔗
American Academy of Physical Medicine and Rehabilitation
Section titled “American Academy of Physical Medicine and Rehabilitation”The American Academy of Physical Medicine and Rehabilitation (AAPM&R) represents physiatrists and rehabilitation physicians. Its relevance to botulinum toxin comes through spasticity, dystonia, ultrasound-guided procedures, and interventional rehabilitation practice.
AAPM&R’s education structure includes annual meeting activity and spasticity-focused certificate programming. In this context, botulinum toxin is part of a broader functional-management and rehabilitation conversation rather than an aesthetic product comparison.
The academy’s future-meeting calendar lists the 2027 Annual Assembly for November 10–13 at the Phoenix Convention Center in Phoenix, Arizona. An edition-specific registration page and program are not yet available.
Websites: AAPM&R Annual Assembly 🔗 and future meeting dates 🔗
Aesthetic Medicine Congresses And Exhibitions
Section titled “Aesthetic Medicine Congresses And Exhibitions”IMCAS World Congress
Section titled “IMCAS World Congress”IMCAS World Congress is a large international congress for dermatology, plastic surgery, and aging science. Its program and exhibition environment make it a major visibility point for injectables, devices, procedural education, and aesthetic medicine companies.
IMCAS matters less as a toxin-specific authority and more as a global marketplace of aesthetic practice. It brings toxin brands, injector education, clinical technique discussion, and medical-aesthetics business development into the same setting.
IMCAS World Congress 2027 is scheduled for January 28–30 in Paris and online. Registration and abstract submission are open. The organizer has also published a preliminary searchable program, although many session descriptions, speakers, and industry-program details remain marked for later announcement.
Website: IMCAS World Congress 2027 🔗
AMWC, the Aesthetic & Anti-Aging Medicine World Congress, is one of the major global medical-aesthetics congress brands. The series includes distinct congresses such as AMWC Cannes 2027, AMWC Korea 2027, and AMWC Japan 2027, each with its own schedule, venue, program, and exhibitor record. Its official materials position the wider series around aesthetic medicine, surgery, longevity, regenerative medicine, wellness, scientific programming, sponsorship, and exhibition.
Botulinum toxin appears in this environment as part of the wider non-surgical aesthetics market. AMWC helps track the professional and commercial context around injectables, but claims made in congress marketing should not be treated as product evidence without separate clinical or regulatory sources.
Website: AMWC 🔗
Vegas Cosmetic Surgery & Aesthetic Dermatology
Section titled “Vegas Cosmetic Surgery & Aesthetic Dermatology”Vegas Cosmetic Surgery & Aesthetic Dermatology is a multispecialty aesthetic conference in the United States. Its official materials emphasize aesthetic surgery, dermatology, live anatomy-based education, nonsurgical technique, patient safety, and injector-focused programming.
Its relevance to botulinum toxin comes from the practical aesthetics side of the market: facial anatomy, injection strategy, complication management, and cross-specialty discussion. It should be read as a clinical education and industry event, not as a source for product equivalence or superiority claims.
The IM-Aesthetics North America calendar 🔗 lists the next edition for 2027 at Fontainebleau Las Vegas. Exact dates, registration details, and an edition-specific program remain pending.
Website: Vegas Cosmetic Surgery & Aesthetic Dermatology 🔗
The Aesthetic Show
Section titled “The Aesthetic Show”The Aesthetic Show is a U.S. medical-aesthetics event associated with a multispecialty audience and an exhibition floor. Its official materials highlight injectables, aesthetic faculty, continuing education, exhibitors, and a broad mix of medical specialties practicing aesthetics.
The Aesthetic Show signals how botulinum toxin sits inside the broader aesthetics business ecosystem. It connects injector education, commercial exhibition, practice management, and product visibility rather than serving as a dedicated neurotoxin-science forum.
The 2027 show is scheduled for July 8–11 at Wynn Las Vegas. Attendee registration and abstract submission are open, with abstracts due October 15, 2026. The organizer has announced broad tracks including injectables, combination treatments, regenerative medicine, integrative aesthetics, devices, and practice management, but a dated session-level program is not yet available.
Website: The Aesthetic Show 🔗
AMWC Korea
Section titled “AMWC Korea”AMWC Korea extends the AMWC congress model into South Korea, one of the most visible aesthetic medicine markets and a major origin country for several botulinum toxin manufacturers. Its official site describes the Seoul event as a congress for aesthetic and anti-aging medical professionals, with scientific programming and an exhibition for products, technologies, and industry connections.
Its relevance is partly regional. Korea’s botulinum toxin industry includes domestic manufacturers, export brands, and international commercialization relationships, so a Korea-based aesthetics congress can help contextualize where clinical education, product visibility, and distribution interest meet.
The 2027 congress is scheduled for June 4–5 at InterContinental Grand Seoul Parnas. Registration and abstract submission have not yet opened; the program, speakers, and edition-specific exhibitor list also remain pending.
Website: AMWC Korea 🔗
AMWC Japan
Section titled “AMWC Japan”AMWC Japan is the Japanese edition of the AMWC congress series. The organizer lists the 2026 meeting for September 12–13 at The Prince Park Tower Tokyo and states that editions from 2027 onward are planned for November.
Registration for 2026 is open. The official 2026 program page 🔗 provides a program PDF and describes AI interpretation in 38 languages, including English and Korean, through attendees’ own devices. Attendees using audio interpretation should bring earphones. These arrangements apply to the 2026 edition.
The AMWC Japan 2027 page tracks the still-pending exact dates, city, venue, registration, program, and exhibitor information. The Japan edition should not be confused with the April 2027 AMWC congress in Cannes or the June 2027 AMWC Korea meeting in Seoul.
Website: AMWC Japan 🔗
Event Context And Evidence Limits
Section titled “Event Context And Evidence Limits”Congress programs indicate which topics, techniques, and products are visible within a professional field. Scientific presentations can inform research context, while exhibitor and sponsor activity reflects commercial visibility rather than clinical evidence.
No meeting or exhibition should be used on its own to infer that two botulinum toxin products are interchangeable, unit-equivalent, equally approved, safer, stronger, longer-lasting, or clinically superior. Product-level interpretation still depends on labels, regulatory status, prescribing information, and high-quality clinical evidence.